Upregulated transcription of SUMF1, FGE‐interacting proteins, and sulfatases initiated by tazarotene and bexarotene could have been an obvious explanation for downstream drug effects in MSD cells. This evidence concerns the gene SUMF1 and Multiple sulfatase deficiency.